BeSt Pharma Management

Ranst ·KBO/BCE: BE 0794.803.647

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	11-08-2025	11 d late	2025-00378220
31-12-2023	31-07-2024	05-08-2024	5 d late	2024-00327203

Metric	This company	Sector median	Position in the sector
Solvency	11.9%	37.5%	better than 20% of 1416 sector peers
Net result	€70k	€45k	better than 59% of 1415 sector peers
Equity	€157k	€365k	better than 34% of 1416 sector peers
Gross operating margin	€129k	€64k	better than 68% of 1414 sector peers
Total assets	€1.32M	€1.42M	better than 48% of 1416 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.32M
Fixed assets	21/28	€1.15M
Tangible fixed assets	22/27	€6k
Financial fixed assets	28	€1.15M
Current assets	29/58	€168k
Amounts receivable within one year	40/41	€117k
Cash & bank	54/58	€51k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.32M
Equity	10/15	€157k
Contributions / capital	10/11	€6k
Accumulated profits (losses)	14	€151k
Amounts payable	17/49	€1.16M
Amounts payable after one year	17	€908k
Amounts payable within one year	42/48	€255k
Trade debts payable within one year	44	€5k
Income statement
Gross operating margin	9900	€129k
Operating result	9901	€128k
Financial charges	65	€39k
Result before taxes	9903	€89k
Income taxes	67/77	€18k
Net result for the period	9904	€70k
Result to be appropriated	9905	€70k

Summary